IDT Barcode Oligos Used to Study Fetal Growth Restriction

IDT’s DECODED newsletter discusses research carried out at North Carolina State University

 

CORALVILLE, IA (7 December 2011) – Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, provides high quality oligonucleotides for use in next generation sequencing (NGS). When used as adapters, these oligonucleotides can be designed to incorporate unique Hamming error-correction that maximizes the accuracy of barcoding individual samples. In the most recent edition of IDT’s quarterly newsletter, DECODED, Ellen Prediger, Director of Scientific Communications at IDT, discusses work carried out by Dr Shengdar Tsai who used IDT oligos that take advantage of Hamming barcoding to create multiplexed next generation sequencing libraries. While a graduate student in the lab of Dr Jorge Piedrahita at North Carolina State University, Dr Tsai performed multiplexed targeted sequence capture to investigate mutations associated with fetal growth restriction, a dangerous pregnancy-related condition that is the second leading cause of prenatal death.

 

To find out more about this story and discover a whole host of additional useful information, download the latest version of Decoded from the IDT website now.

 

About IDT

Integrated DNA Technologies (IDT) is the largest supplier of custom nucleic acids in the United States, serving academic, government, and commercial researchers in biotechnology, clinical diagnostics, and pharmaceutical development. IDT's primary business is the manufacture of custom, synthetic DNA and RNA oligonucleotides. Today, IDT synthesizes and ships an average of 36,000 custom oligos per day to more than 86,000 customers worldwide. IDT manufacturing locations include facilities in Coralville, Iowa; San Diego, Calif.; and Leuven, Belgium. For more information visit www.idtdna.com.

 

Integrated DNA Technologies

800-328-2661 (US & Canada)

+1 319-626-8400 (outside US)

productinfo@idtdna.com

www.idtdna.com